217 related articles for article (PubMed ID: 32814173)
1. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
Son Y; Lim D; Park S; Song IS; Kim JH; Shin S; Jang H; Liu KH; O Y; Song GY; Kang W; Cho YS; Na M; Chung H; Oh S
Pharmacol Res; 2020 Nov; 161():105146. PubMed ID: 32814173
[TBL] [Abstract][Full Text] [Related]
2. Agents that bind annexin A2 suppress ocular neovascularization.
Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
[TBL] [Abstract][Full Text] [Related]
3. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
5. COL10A1 is a novel factor in the development of choroidal neovascularization.
Lv D; Chen D; Wang Z; Cui Z; Ma JH; Ji S; Chen J; Tang S
Microvasc Res; 2022 Jan; 139():104239. PubMed ID: 34520774
[TBL] [Abstract][Full Text] [Related]
6. Fibulin-7 C-terminal fragment and its active synthetic peptide suppress choroidal and retinal neovascularization.
Ikeuchi T; Kanan Y; Long D; de Vega S; Hozumi K; Nomizu M; Campochiaro PA; Yamada Y
Microvasc Res; 2020 May; 129():103986. PubMed ID: 32017943
[TBL] [Abstract][Full Text] [Related]
7. Wnt5a/β-catenin-mediated epithelial-mesenchymal transition: a key driver of subretinal fibrosis in neovascular age-related macular degeneration.
Liu D; Du J; Xie H; Tian H; Lu L; Zhang C; Xu GT; Zhang J
J Neuroinflammation; 2024 Mar; 21(1):75. PubMed ID: 38532410
[TBL] [Abstract][Full Text] [Related]
8. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
9. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
[TBL] [Abstract][Full Text] [Related]
10. Retinal angiogenesis suppression through small molecule activation of p53.
Chavala SH; Kim Y; Tudisco L; Cicatiello V; Milde T; Kerur N; Claros N; Yanni S; Guaiquil VH; Hauswirth WW; Penn JS; Rafii S; De Falco S; Lee TC; Ambati J
J Clin Invest; 2013 Oct; 123(10):4170-81. PubMed ID: 24018558
[TBL] [Abstract][Full Text] [Related]
11. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
12. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.
Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
14. Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin Internalization.
De Rossi G; Vähätupa M; Cristante E; Arokiasamy S; Liyanage SE; May U; Pellinen L; Uusitalo-Järvinen H; Bainbridge JW; Järvinen TAH; Whiteford JR
Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1374-1389. PubMed ID: 33596666
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Efficacy of a Novel Acetylated Tetrapeptide in Animal Models of Age-Related Macular Degeneration.
Koo HC; Baek YY; Choi JS; Kim YM; Sung B; Kim MJ; Kim JG; You JC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918777
[TBL] [Abstract][Full Text] [Related]
16. Ilimaquinone and ethylsmenoquinone, marine sponge metabolites, suppress the proliferation of multiple myeloma cells by down-regulating the level of β-catenin.
Park S; Yun E; Hwang IH; Yoon S; Kim DE; Kim JS; Na M; Song GY; Oh S
Mar Drugs; 2014 May; 12(6):3231-44. PubMed ID: 24879546
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
[TBL] [Abstract][Full Text] [Related]
18. "One stone and two birds" strategy to treat neovascular age-related macular degeneration by a novel retinoid drug, EYE-101.
Xu M; Shen YM; Han XY; Liu C; Jiang Q; Cao X; Yan B
Exp Eye Res; 2023 Feb; 227():109385. PubMed ID: 36638858
[TBL] [Abstract][Full Text] [Related]
19. The HIF-1α/p53/miRNA-34a/Klotho axis in retinal pigment epithelial cells promotes subretinal fibrosis and exacerbates choroidal neovascularization.
Xie L; Wang Y; Li Q; Ji X; Tu Y; Du S; Lou H; Zeng X; Zhu L; Zhang J; Zhu M
J Cell Mol Med; 2021 Feb; 25(3):1700-1711. PubMed ID: 33438362
[TBL] [Abstract][Full Text] [Related]
20. Curcumolide, a unique sesquiterpenoid from Curcuma wenyujin displays anti-angiogenic activity and attenuates ischemia-induced retinal neovascularization.
Lin W; Tu H; Zhu Y; Guan Y; Liu H; Ling W; Yan P; Dong J
Phytomedicine; 2019 Nov; 64():152923. PubMed ID: 31450226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
